VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

8306	Companies
115328	Keywords
55598	Articles
62613	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/17/2024 at 17:40, 5 months 4 days ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 5 months 16 days ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 06/06/2024 at 10:58, 5 months 16 days ago

Valbiotis met fin à son accord de licence avec Nestlé Health Science

Valbiotis TOTUM•63 Traitement Du Diabète Contrat De Licence Nestlé Sciences De La Santé
PRESS RELEASE

published on 06/06/2024 at 10:53, 5 months 16 days ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 5 months 16 days ago

Valbiotis et Nestlé Health Science mettent fin à leur contrat de licence et d’approvisionnement

Valbiotis Compléments Alimentaires Propriété Intellectuelle TOTUM•63 Nestlé
BRIEF

published on 06/06/2024 at 10:49, 5 months 16 days ago

Valbiotis and Nestlé Health Science terminate their licensing and supply agreement

Valbiotis Intellectual Property TOTUM•63 Food Supplements Nestlé
PRESS RELEASE

published on 06/06/2024 at 10:44, 5 months 16 days ago

Valbiotis annonce un accord avec Nestlé Health Science actant la fin du contrat de licence et d’approvisionnement
Valbiotis annonce la fin de son contrat de licence avec Nestlé Health Science en reprenant la propriété intellectuelle de TOTUM•63, renforçant son portefeuille de produits pour le diabète

Valbiotis Propriété Intellectuelle Diabète Contrat De Licence TOTUM 63
BRIEF

published on 06/04/2024 at 08:05, 5 months 18 days ago

Valbiotis et Nestlé Health Science mettent fin à leur contrat de licence

Valbiotis Propriété Intellectuelle Complément Alimentaire Nestlé Health Science Diabète
BRIEF

published on 06/04/2024 at 08:05, 5 months 18 days ago

Valbiotis and Nestlé Health Science terminate their licensing agreement

Diabetes Valbiotis Intellectual Property Dietary Supplement Nestlé Health Science
PRESS RELEASE

published on 06/04/2024 at 08:00, 5 months 18 days ago

Valbiotis annonce un accord avec Nestlé Health Science actant la fin du contrat de licence et d’approvisionnement
Valbiotis annonce la fin de son contrat de licence avec Nestlé Health Science concernant TOTUM•63, son complément alimentaire végétal pour la prise en charge du prédiabète et du diabète de type 2. Accord acté pour récupération de la propriété intellectuelle

Valbiotis Compléments Alimentaires Propriété Intellectuelle TOTUM•63 Nestlé Health Science

Accesswire

Published on 11/22/2024 at 16:00, 1 hour 32 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 37 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 17 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 2 hours 47 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 2 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 16:55, 36 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 hour 32 minutes ago

Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 32 minutes ago

AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 2 hours 5 minutes ago

EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 2 hours 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company

Les Echos

Published on 11/22/2024 at 16:15, 1 hour 16 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 2 hours 57 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 2 hours 57 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE